nach oben

Pediatric Radiology

Erschienen in:

01.02.2011 | Review

Clinical applications in molecular imaging

verfasst von: Carola Heneweer, Jan Grimm

Erschienen in: Pediatric Radiology | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Molecular imaging is aimed at the noninvasive in vivo characterization and measurement of processes at a cellular and molecular level with clinical imaging methods. Contrast agents are constructed to target markers that are specific either for certain diseases or for functional states of specialized tissues. Efforts are currently focused mainly on processes involved in angiogenesis, inflammation, and apoptosis. Cell tracking is performed for diagnostic purposes as well as for monitoring of novel cell therapies. Visualization of these processes would provide more precise information about disease expansion as well as treatment response, and could lead to a more individualized therapy for patients. Many attempts have shown promising results in preclinical studies; however, translation into the clinic remains a challenge. This applies especially to paediatrics because of more stringent safety concerns and the low prevalence of individual diseases. The most promising modalities for clinical translation are nuclear medicine methods (positron emission tomography [PET] and single photon emission CT [SPECT]) due to their high sensitivity, which allows concentrations below biological activity. However, special dose consideration is required for any application of ionizing radiation especially in children. While very little has been published on molecular imaging in a paediatric patient population beyond fluorodeoxyglucose (FDG)-PET and metaiodobenzylguanidine (MIBG) tracers, this review will attempt to discuss approaches that we believe have promise for paediatric imaging. These will include agents that already reached clinical trials as well as preclinical developments with high potential for clinical application.

Weissleder R, Mahmood U (2001) Molecular imaging. Radiology 219:316–333PubMed

Grimm J, Wunder A (2005) Current state of molecular imaging research. Rofo 177:326–337PubMed

Frangioni JV (2006) Translating in vivo diagnostics into clinical reality. Nat Biotechnol 24:909–913CrossRefPubMed

Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70CrossRefPubMed

Massoud TF, Gambhir SS (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17:545–580CrossRefPubMed

Blankenberg FG (2008) In vivo imaging of apoptosis. Cancer Biol Ther 7:1525–1532CrossRefPubMed

De Saint-Hubert M, Prinsen K, Mortelmans L et al (2009) Molecular imaging of cell death. Methods 48:178–187CrossRefPubMed

Ventura A, Kirsch DG, McLaughlin ME et al (2007) Restoration of p53 function leads to tumour regression in vivo. Nature 445:661–665CrossRefPubMed

Fadok VA, Voelker DR, Campbell PA et al (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148:2207–2216PubMed

10.

Boersma HH, Kietselaer BL, Stolk LM et al (2005) Past, present, and future of annexin A5: from protein discovery to clinical applications. J Nucl Med 46:2035–2050PubMed

11.

van de Wiele C, Lahorte C, Vermeersch H et al (2003) Quantitative tumor apoptosis imaging using technetium-99 m-HYNIC annexin V single photon emission computed tomography. J Clin Oncol 21:3483–3487CrossRefPubMed

12.

Haas RL, de Jong D, Valdes Olmos RA et al (2004) In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients. Int J Radiat Oncol Biol Phys 59:782–787CrossRefPubMed

13.

Kurihara H, Yang DJ, Cristofanilli M et al (2008) Imaging and dosimetry of 99mTc EC annexin V: preliminary clinical study targeting apoptosis in breast tumors. Appl Radiat Isot 66:1175–1182CrossRefPubMed

14.

Belhocine T, Steinmetz N, Hustinx R et al (2002) Increased uptake of the apoptosis-imaging agent (99 m)Tc recombinant human annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clin Cancer Res 8:2766–2774PubMed

15.

Thimister PW, Hofstra L, Liem IH et al (2003) In vivo detection of cell death in the area at risk in acute myocardial infarction. J Nucl Med 44:391–396PubMed

16.

Lorberboym M, Blankenberg FG, Sadeh M et al (2006) In vivo imaging of apoptosis in patients with acute stroke: correlation with blood-brain barrier permeability. Brain Res 1103:13–19CrossRefPubMed

17.

Kietselaer BL, Reutelingsperger CP, Boersma HH et al (2007) Noninvasive detection of programmed cell loss with 99mTc-labeled annexin A5 in heart failure. J Nucl Med 48:562–567CrossRefPubMed

18.

Van den Brande JM, Koehler TC, Zelinkova Z et al (2007) Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn’s disease. Gut 56:509–517CrossRefPubMed

19.

Yagle KJ, Eary JF, Tait JF et al (2005) Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis. J Nucl Med 46:658–666PubMed

20.

Murakami Y, Takamatsu H, Taki J et al (2004) 18F-labelled annexin V: a PET tracer for apoptosis imaging. Eur J Nucl Med Mol Imaging 31:469–474CrossRefPubMed

21.

Zhang X, Paule MG, Newport GD et al (2009) A minimally invasive, translational biomarker of ketamine-induced neuronal death in rats: microPET Imaging using 18F-annexin V. Toxicol Sci 111:355–361CrossRefPubMed

22.

Sosnovik DE, Garanger E, Aikawa E et al (2009) Molecular MRI of cardiomyocyte apoptosis with simultaneous delayed-enhancement MRI distinguishes apoptotic and necrotic myocytes in vivo: potential for midmyocardial salvage in acute ischemia. Circ Cardiovasc Imaging 2:460–467CrossRefPubMed

23.

Smith BR, Heverhagen J, Knopp M et al (2007) Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI). Biomed Microdevices 9:719–727CrossRefPubMed

24.

Cohen A, Shirvan A, Levin G et al (2009) From the Gla domain to a novel small-molecule detector of apoptosis. Cell Res 19:625–637CrossRefPubMed

25.

Grimberg H, Levin G, Shirvan A et al (2009) Monitoring of tumor response to chemotherapy in vivo by a novel small-molecule detector of apoptosis. Apoptosis 14:257–267CrossRefPubMed

26.

Aird WC (2005) Spatial and temporal dynamics of the endothelium. J Thromb Haemost 3:1392–1406CrossRefPubMed

27.

Endemann DH, Schiffrin EL (2004) Endothelial dysfunction. J Am Soc Nephrol 15:1983–1992CrossRefPubMed

28.

Reynolds PR, Larkman DJ, Haskard DO et al (2006) Detection of vascular expression of E-selectin in vivo with MR imaging. Radiology 241:469–476CrossRefPubMed

29.

Kaufmann BA, Carr CL, Belcik JT et al (2010) Molecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of disease. Arterioscler Thromb Vasc Biol 30:54–59CrossRefPubMed

30.

Behm CZ, Kaufmann BA, Carr C et al (2008) Molecular imaging of endothelial vascular cell adhesion molecule-1 expression and inflammatory cell recruitment during vasculogenesis and ischemia-mediated arteriogenesis. Circulation 117:2902–2911CrossRefPubMed

31.

Boutry S, Burtea C, Laurent S et al (2005) Magnetic resonance imaging of inflammation with a specific selectin-targeted contrast agent. Magn Reson Med 53:800–807CrossRefPubMed

32.

Nahrendorf M, Jaffer FA, Kelly KA et al (2006) Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 114:1504–1511CrossRefPubMed

33.

Funovics M, Montet X, Reynolds F et al (2005) Nanoparticles for the optical imaging of tumor E-selectin. Neoplasia 7:904–911CrossRefPubMed

34.

Mulder WJ, Strijkers GJ, Griffioen AW et al (2004) A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets. Bioconjug Chem 15:799–806CrossRefPubMed

35.

Ferrante EA, Pickard JE, Rychak J et al (2009) Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flow. J Control Release 140:100–107CrossRefPubMed

36.

Bachmann C, Klibanov AL, Olson TS et al (2006) Targeting mucosal addressin cellular adhesion molecule (MadCAM)-1 to noninvasively image experimental Crohn’s disease. Gastroenterology 130:8–16CrossRefPubMed

37.

Jamar F, Houssiau FA, Devogelaer JP et al (2002) Scintigraphy using a technetium 99 m-labelled anti-E-selectin Fab fragment in rheumatoid arthritis. Rheumatology (Oxford) 41:53–61CrossRef

38.

Kiessling F (2008) Noninvasive cell tracking. Handb Exp Pharmacol 185:305–321CrossRefPubMed

39.

Grimm J, Kircher MF, Weissleder R (2007) Cell tracking. Principles and applications. Radiologe 47:25–33CrossRefPubMed

40.

Hofmann M, Wollert KC, Meyer GP et al (2005) Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111:2198–2202CrossRefPubMed

41.

Dousset V, Brochet B, Deloire MS et al (2006) MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium. AJNR 27:1000–1005PubMed

42.

Saleh A, Schroeter M, Jonkmanns C et al (2004) In vivo MRI of brain inflammation in human ischaemic stroke. Brain 127:1670–1677CrossRefPubMed

43.

Trivedi RA, Mallawarachi C, U-King-Im JM et al (2006) Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler Thromb Vasc Biol 26:1601–1606CrossRefPubMed

44.

Bennink RJ, Thurlings RM, van Hemert FJ et al (2008) Biodistribution and radiation dosimetry of 99mTc-HMPAO-labeled monocytes in patients with rheumatoid arthritis. J Nucl Med 49:1380–1385CrossRefPubMed

45.

Thoeny HC, Triantafyllou M, Birkhaeuser FD et al (2009) Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. Eur Urol 55:761–769CrossRefPubMed

46.

Kimura K, Tanigawa N, Matsuki M et al (2009) High-resolution MR lymphography using ultrasmall superparamagnetic iron oxide (USPIO) in the evaluation of axillary lymph nodes in patients with early stage breast cancer: preliminary results. Breast Cancer 17:241–246CrossRefPubMed

47.

Pultrum BB, van der Jagt EJ, van Westreenen HL et al (2009) Detection of lymph node metastases with ultrasmall superparamagnetic iron oxide (USPIO)-enhanced magnetic resonance imaging in oesophageal cancer: a feasibility study. Cancer Imaging 9:19–28CrossRefPubMed

48.

Tokuhara T, Tanigawa N, Matsuki M et al (2008) Evaluation of lymph node metastases in gastric cancer using magnetic resonance imaging with ultrasmall superparamagnetic iron oxide (USPIO): diagnostic performance in post-contrast images using new diagnostic criteria. Gastric Cancer 11:194–200CrossRefPubMed

49.

Modak S, Cheung NK (2010) Neuroblastoma: Therapeutic strategies for a clinical enigma. Cancer Treat Rev 36:307–317CrossRefPubMed

50.

Beckmann N, Cannet C, Fringeli-Tanner M et al (2003) Macrophage labeling by SPIO as an early marker of allograft chronic rejection in a rat model of kidney transplantation. Magn Reson Med 49:459–467CrossRefPubMed

51.

Kanno S, Lee PC, Dodd SJ et al (2000) A novel approach with magnetic resonance imaging used for the detection of lung allograft rejection. J Thorac Cardiovasc Surg 120:923–934CrossRefPubMed

52.

Kanno S, Wu YJ, Lee PC et al (2001) Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation 104:934–938CrossRefPubMed

53.

Mulder WJ, Strijkers GJ, Briley-Saboe KC et al (2007) Molecular imaging of macrophages in atherosclerotic plaques using bimodal PEG-micelles. Magn Reson Med 58:1164–1170CrossRefPubMed

54.

Kircher MF, Grimm J, Swirski FK et al (2008) Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesions. Circulation 117:388–395CrossRefPubMed

55.

Pittet MJ, Grimm J, Berger CR et al (2007) In vivo imaging of T cell delivery to tumors after adoptive transfer therapy. Proc Natl Acad Sci USA 104:12457–12461CrossRefPubMed

56.

Tawakol A, Migrino RQ, Bashian GG et al (2006) In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 48:1818–1824CrossRefPubMed

57.

Azzi J, Geara AS, El-Sayegh S et al (2010) Immunological aspects of pancreatic islet cell transplantation. Expert Rev Clin Immunol 6:111–124CrossRefPubMed

58.

Kraitchman DL, Bulte JW (2009) In vivo imaging of stem cells and Beta cells using direct cell labeling and reporter gene methods. Arterioscler Thromb Vasc Biol 29:1025–1030CrossRefPubMed

59.

Turkbey B, Kobayashi H, Ogawa M et al (2009) Imaging of tumor angiogenesis: functional or targeted? AJR 193:304–313CrossRefPubMed

60.

Nessa A, Latif SA, Siddiqui NI et al (2009) Angiogenesis-a novel therapeutic approach for ischemic heart disease. Mymensingh Med J 18:264–272PubMed

61.

Sneider EB, Nowicki PT, Messina LM (2009) Regenerative medicine in the treatment of peripheral arterial disease. J Cell Biochem 108:753–761CrossRefPubMed

62.

Baeriswyl V, Christofori G (2009) The angiogenic switch in carcinogenesis. Semin Cancer Biol 19:329–337CrossRefPubMed

63.

Cortes-Funes H (2009) The role of antiangiogenesis therapy: bevacizumab and beyond. Clin Transl Oncol 11:349–355CrossRefPubMed

64.

Jayson GC, Zweit J, Jackson A et al (2002) Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implications for trial design of antiangiogenic antibodies. J Natl Cancer Inst 94:1484–1493PubMed

65.

Blankenberg FG, Levashova Z, Sarkar SK et al (2010) Noninvasive assessment of tumor VEGF receptors in response to treatment with pazopanib: a molecular imaging study. Transl Oncol 3:56–64PubMed

66.

Dijkgraaf I, Boerman OC (2009) Radionuclide imaging of tumor angiogenesis. Cancer Biother Radiopharm 24:637–647CrossRefPubMed

67.

Schnell O, Krebs B, Carlsen J et al (2009) Imaging of integrin alpha(v)beta(3) expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography. Neuro Oncol 11:861–870CrossRefPubMed

68.

Beer AJ, Niemeyer M, Carlsen J et al (2008) Patterns of alphavbeta3 expression in primary and metastatic human breast cancer as shown by 18F-Galacto-RGD PET. J Nucl Med 49:255–259CrossRefPubMed

69.

Beer AJ, Grosu AL, Carlsen J et al (2007) [18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 13:6610–6616CrossRefPubMed

70.

Beer AJ, Haubner R, Sarbia M et al (2006) Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man. Clin Cancer Res 12:3942–3949CrossRefPubMed

71.

Bach-Gansmo T, Bogsrud TV, Skretting A (2008) Integrin scintimammography using a dedicated breast imaging, solid-state gamma-camera and (99 m)Tc-labelled NC100692. Clin Physiol Funct Imaging 28:235–239CrossRefPubMed

72.

Kenny LM, Coombes RC, Oulie I et al (2008) Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients. J Nucl Med 49:879–886CrossRefPubMed

73.

Chengazi VU, Feneley MR, Ellison D et al (1997) Imaging prostate cancer with technetium-99m-7E11-C5.3 (CYT-351). J Nucl Med 38:675–682PubMed

74.

Morris MJ, Pandit-Taskar N, Divgi CR et al (2007) Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumors. Clin Cancer Res 13:2707–2713CrossRefPubMed

75.

Bakhshi S, Radhakrishnan V (2010) Prognostic markers in osteosarcoma. Expert Rev Anticancer Ther 10:271–287CrossRefPubMed

76.

Wachtel M, Schafer BW (2010) Targets for cancer therapy in childhood sarcomas. Cancer Treat Rev 36:318–327CrossRefPubMed

Titel: Clinical applications in molecular imaging
verfasst von: Carola Heneweer
Jan Grimm
Publikationsdatum: 01.02.2011
Verlag: Springer-Verlag
Erschienen in: Pediatric Radiology / Ausgabe 2/2011
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI: https://doi.org/10.1007/s00247-010-1902-5

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Clinical applications in molecular imaging

Abstract

Neu im Fachgebiet Radiologie

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

Akuter Schwindel: Wann lohnt sich eine MRT?

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

S3-Leitlinie zu Pankreaskrebs aktualisiert

Update Radiologie

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2011

Minisymposium: molecular imaging

Haemodynamic findings on cardiac CT in children with congenital heart disease

L.S. Medina, K. E. Applegate, C.C. Blackmore (eds): Evidence-based imaging in pediatrics: optimizing imaging in pediatric patient care

Hermes

High signal in bone marrow at diffusion-weighted imaging with body background suppression (DWIBS) in healthy children

Molecular ultrasound imaging and its potential for paediatric radiology

Neu im Fachgebiet Radiologie

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

Akuter Schwindel: Wann lohnt sich eine MRT?

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

S3-Leitlinie zu Pankreaskrebs aktualisiert

Update Radiologie